Abstract LB-219: ApoE and its' receptors (LRP8, VLDLR) function as growth signals for triple-negative breast cancer and represents novel therapeutic targets
Christine Y. Shiang(The University of Texas MD Anderson Cancer Center), Lajos Pusztai(Yale University), Bradley M. Broom(The University of Texas MD Anderson Cancer Center), Yuan Qi(The University of Texas MD Anderson Cancer Center), Bailiang Wang(The University of Texas MD Anderson Cancer Center)
Cited by 3
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k